Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension Due to Idiopathic Myelofibrosis

スポンサーリンク

概要

• 論文の詳細を見る

• A 59-year-old man was diagnosed to have idiopathic myelofibrosis (IMF) in November 2001. In April 2004, massive ascites and esophageal varices were found. IMF was considered to be the cause of portal hypertension (ascites and esophageal varices). Since ascites tend to be intractable with diuretic drugs, a transjugular intrahepatic portosystemic shunt (TIPS) was inserted in May 2004. Before TIPS, his waist measured 98 cm. On day74 after TIPS, his waist measured 68 cm as a result of the administration of diuretic drugs alone. He eventually died due to hepatic failure on day 168 after TIPS. The autopsy findings suggest that sinusoidal fibrosis caused portal hypertension.

• 社団法人 日本内科学会の論文

著者

• MIYAWAKI Shuichi

  the Department of Internal Medicine, Saiseikai Maebashi Hospital

• Sakura Tohru

  The Division of Hematology, Saiseikai Maebashi Hospital, Maebashi

• Doki Noriko

  The Division of Hematology, Saiseikai Maebashi Hospital, Maebashi

• Irisawa Hiroyuki

  The Division of Hematology, Saiseikai Maebashi Hospital, Maebashi

• Takada Satoru

  The Division of Hematology, Saiseikai Maebashi Hospital, Maebashi

• Miyawaki Shuichi

  The Division of Hematology, Saiseikai Maebashi Hospital, Maebashi

関連論文

• Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
• Splenic Lymphoma with Villous Lymphocytes with CD5+, CDllc+ B-Cell Phenotype
• Transjugular Intrahepatic Portosystemic Shunt for the Treatment of Portal Hypertension Due to Idiopathic Myelofibrosis

スポンサーリンク